Skip to main content

Month: August 2021

Dorman Products, Inc. Completes Acquisition of Dayton Parts and Provides Updated 2021 Guidance

COLMAR, Pa., Aug. 10, 2021 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ:DORM), a leading supplier in the automotive aftermarket industry, today announced that it completed the acquisition of Dayton Parts (“Dayton”) for a total cash consideration of approximately $338 million, subject to customary purchase price adjustments. The transaction was financed with $100 million from cash on hand, with the balance financed from borrowings under the Company’s new revolving credit facility. Simultaneous with the closing of the transaction, Dorman entered into a new $600 million 5-year revolving credit facility, which replaces its existing $100 million revolving credit facility. The strong cash flow generation of the combined companies, together with the new revolving credit facility, are expected to provide...

Continue reading

Mercury Systems recognized by Lockheed Martin for outstanding performance

ANDOVER, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a leader in trusted, secure mission-critical technologies for aerospace and defense, announced that its Torrance, Calif. facility was recognized by Lockheed Martin Rotary and Mission Systems (RMS) for its exemplary contributions to delivering advanced products and services in 2020. The RMS Elite Supplier award for providing outstanding quality and delivery is a culmination of the Torrance team’s hard work and dedication to customer satisfaction over the past five years. “We’re honored and proud to be recognized by Lockheed Martin for our performance throughout 2020 with this prestigious award,” said Jay Abendroth, vice president and general manager, Mercury Mission. “Lockheed Martin has been a valuable longstanding partner and we...

Continue reading

Casella Waste Systems, Inc. to Present at Upcoming Investor Conference

RUTLAND, Vt., Aug. 10, 2021 (GLOBE NEWSWIRE) — Casella Waste Systems, Inc. (Nasdaq: CWST), a regional solid waste, recycling, and resource management services company, announced today that the company’s management will be presenting at the following investor conference:Raymond James Diversified Industrials ConferenceTuesday, August 24, 2021A copy of the presentation for the conferences will be available shortly before the Company presents and may be accessed via the Investors’ section of the company’s website at http://ir.casella.com. In addition, the conference will be webcast live via a link on the company’s website. For further information, contact Ned Coletta, Chief Financial Officer at (802) 772-2239, or visit the company’s website at http://www.casella.com.

Continue reading

Codex DNA Reports Second Quarter 2021 Financial Results

SAN DIEGO, Aug. 10, 2021 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today reported financial results for the second quarter ended June 30, 2021. “During the second quarter, Codex DNA took a big step forward in the evolution of our business. We successfully closed an IPO, strengthened the diversity of our leadership team and Board of Directors, enabled new downstream mRNA applications, expanded our customer base, and grew revenue 76% year over year,” said Todd R. Nelson, PhD, CEO of Codex DNA. “We are now well positioned to build on this foundation, scale our global operations, and empower more customers with the ability to rapidly create sustainable solutions to help advance precision medicine, biologics drug discovery, vaccine development, genome editing, and cell...

Continue reading

REE Automotive, Ltd. Announces Date for Second Quarter 2021 Financial Results Release, Webcast and Conference Call

NEW YORK and TEL-AVIV, Israel, Aug. 10, 2021 (GLOBE NEWSWIRE) — REE Automotive, Ltd. (NASDAQ: REE) (“REE” or the “Company”), a leader in e-mobility, announced today that the Company will release its second quarter 2021 financial results before the NASDAQ market opens on Tuesday, August 17, 2021. A webcast and conference call will be held on August 17, 2021, at 08:30 a.m. Eastern time to review the Company’s second quarter results, discuss recent developments and conduct a question-and-answer session. The live webcast and archived replay of the conference call can be accessed via the Events and Presentations page of REE’s Investor Relations website at https://investors.ree.auto/. For those unable to access the webcast or would like to ask questions, the conference call will be accessible domestically or internationally, by dialing...

Continue reading

Newtek Business Services Corp. Declares Third Quarter 2021 Dividend of $0.90 per Share

Represents a 55.2% Increase over the Third Quarter 2020 Dividend BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp., (NASDAQ: NEWT), an internally managed business development company (“BDC”), today announced that its Board of Directors declared a third quarter 2021 cash dividend of $0.901 per share. The third quarter 2021 dividend is payable on September 30, 2021 to shareholders of record as of September 20, 2021. The payment of the third quarter 2021 dividend would represent a 55.2% increase over the third quarter 2020 dividend of $0.58 per share. With the payment of the third quarter 2021 dividend, the Company will have paid $2.10 per share in dividends for the first three quarters of 2021, which would represent a 32.9% increase over dividends paid for the first three quarters of 2020. Note regarding...

Continue reading

StepStone Group Reports First Quarter Fiscal Year 2022 Results

NEW YORK, Aug. 10, 2021 (GLOBE NEWSWIRE) — StepStone Group Inc. (Nasdaq: STEP), a global private markets investment firm focused on providing customized investment solutions and advisory and data services, today reported results for the quarter ended June 30, 2021. This represents results for the first quarter for the fiscal year ending March 31, 2022. The Board of Directors of the Company has declared a quarterly cash dividend of $0.07 per share of Class A common stock, payable on September 15, 2021, to the holders of record as of the close of business on August 31, 2021. StepStone issued a full detailed presentation of its first quarter fiscal 2022 results, which can be accessed by clicking here. Webcast and Earnings Conference Call Management will host a webcast and conference call on Tuesday, August 10, 2021 at 5:00 pm ET to...

Continue reading

Inari Medical Reports Second Quarter 2021 Financial Results 

IRVINE, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported financial results for its second quarter ended June 30, 2021. Second Quarter Revenue and Business Highlights:Treated a record number of patients, with revenue of $63.5 million for the second quarter of 2021, up 11% sequentially and 150% year-over-year. Announced FDA clearance of FlowSaver, enabling bloodless thrombectomy with the use of Triever Catheters. Presented interim results of the CLOUT DVT registry at New Cardiovascular Horizons, confirming best in class safety, clot removal, and clinical results for patients treated with ClotTriever. Ended the quarter with $176.1...

Continue reading

Oncocyte Reports Second Quarter 2021 Financial Results and Provides Corporate Update

DetermaRx Q2 Sample Volume Grows 23% over Q1 2021 Potential pan-cancer utility of DetermaIO strengthened by data in breast, lung, bladder and renal cell cancer, validating the test in all four tumor types evaluated; upcoming oral presentation of randomized clinical trial in TNBC at ESMO Chronix acquisition positions Oncocyte to enter growing field of blood-based monitoring for immune therapy response and transplant rejection testing Conference Call to be held today at 4:30 pm ET/ 1:30 pm PDT  IRVINE, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, reports financial results for the second quarter...

Continue reading

Altimmune Announces Second Quarter 2021 Financial Results and Provides a Corporate Update

12-week Data Readout from ALT-801 Phase 1 Clinical Trial Expected in September        Approximately $218 Million in Cash and Short-Term Investments to Advance Obesity and Liver Disease Pipeline GAITHERSBURG, Md., Aug. 10, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the three- and six-months ending June 30, 2021 and provided a corporate update. “Following data readouts in Q2, Altimmune has focused its efforts on our NASH and emerging obesity pipeline with the encouraging interim data from the ALT-801 Phase 1 trial reinforcing the potential of these programs,” remarked Vipin K. Garg, Ph.D., President and Chief Executive Officer at Altimmune. “Our strong financial position enables us to proceed with a robust ALT-801 development program in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.